Sage Therapeutics to Present at the Goldman Sachs 44th Annual Global H...

Your unfiltered news center. ®

The world you see depends upon the news you get. ®

HOME

ARTS

RSS

Today's Date: April 27, 2024

Badger Meter Declares Regular Quarterly Dividend • Levy Konigsberg Files Lawsuits on Behalf of 25 Men Who Allege They Were Sexually Abused as Juveniles Across Four New Jersey Juve • 29 London Partners With US Media Company Bobi Media to Strengthen Market Offering • Carbon Removal and Mariculture Legislation Moves Forward in California Assembly • Anti-Mullerian Hormone Test Market Projected to Reach $586.48 million by 2030 - Exclusive Report by 360iResearch • Latin America CDC a Must, say Public Health Leaders and AHF • Greenberg Traurig is a Finalist for Legal Media Group's 2024 Women in Business Law EMEA Awards • Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions • Whitman-Walker Institute Applauds the Biden-Harris Administration for Finalizing Robust Affordable Care Act Nondiscrimination Pr • CareTrust REIT Sets First Quarter Earnings Call for Friday, May 3, 2024 • L.A. Care and Blue Shield of California Promise Health Plans Celebrate New Community Resource Center in West Los Angeles, Highli • Brothers to Host Grand Opening Event for JDog Junk Removal & Hauling Business on April 28th • Suzano 2023 annual report on Form 20-F • Broadstone Net Lease Issues 2023 Sustainability Report • US Marine Corps Veteran to Celebrate Grand Opening of JDog Junk Removal & Hauling in Findlay on May 4th • Books-A-Million Launches Its 22nd Coffee for the Troops Donation Campaign • Getting Tattooed with Gay History • Toro Taxes, the Leading Latino Tax Franchise selects Trez, to power Payroll solutions • Chase Opens Innovative Branch in Bronx’s Grand Concourse Neighborhood • The Sallie Mae Fund Grants $75,000 to DC College Access Program to Support Higher Education Access and Completion

Sage Therapeutics to Present at the Goldman Sachs 44th Annual Global Healthcare Conference

CAMBRIDGE, Mass. , June 05 /Businesswire/ - Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that the Company will participate in a fireside chat at the Goldman Sachs 44^th Annual Global Healthcare Conference on Monday, June 12, 2023, at 11:20 a.m. PT in Dana Point, CA.

A live webcast of the presentation can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit www.sagerx.com.